![](data:image/svg+xml;charset=utf-8,<svg height="32" width="135" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
₹ 18,805.80
As on 07 May 2024, 06:47:57
| Fiscal Period | Absolute% | Annualised% |
|---|---|---|
| 1 Week | -1.02 | - |
| 1 Month | -2.30 | - |
| 3 Months | 1.15 | - |
| 6 Months | 22.96 | - |
| 1 Year | 48.29 | - |
| 2 Year | 46.87 | 21.19 |
| 3 Year | 36.59 | 10.95 |
| 5 Year | 105.26 | 15.47 |
| Stock Name | Cur Price | Change (% chg) | Sector |
|---|---|---|---|
| Abbott India | 25,447.65 | -325.40 (-1.26) | Healthcare |
| Alkem Laboratories | 5,063.85 | -85.10 (-1.65) | Healthcare |
| Aurobindo Pharma | 1,105.05 | -58.15 (-5.00) | Healthcare |
| Biocon | 297.25 | -3.35 (-1.11) | Healthcare |
| Cipla | 1,384.50 | -38.90 (-2.73) | Healthcare |
| Divis Laboratories | 3,904.95 | -58.05 (-1.46) | Healthcare |
| Dr Reddys Laboratories | 6,250.00 | -43.45 (-0.69) | Healthcare |
| Stock Name | Cur Price | Change (% chg) |
|---|
| Stock Name | Cur Price | Change (% chg) |
|---|---|---|
| Aurobindo Pharma | 1,105.05 | -58.15 (-5.00) |
| Lupin | 1,598.05 | -81.60 (-4.86) |
| Zydus Lifesciences | 984.05 | -36.70 (-3.60) |
| Glenmark Pharmaceuticals | 1,003.95 | -36.70 (-3.53) |
| IPCA Laboratories | 1,289.45 | -46.85 (-3.51) |
MF central: Manage accounts with multiple fund houses at one unified platform; Here's how
Stock Check: JSW Infra jumps almost 100% from IPO price in 5 months; should you still buy?
Axis Mobile App ranks top position on NPS leaderboard
Weekend Wrap: From Trent to Adani Power, top news and market movers this week: 27 October 2023
Why rebalancing a portfolio provides a safety net against volatility?